Drug recall · July 10, 2013
Prempro recall
Why: Failed Dissolution Specifications: Pfizer Inc. is recalling PREMPRO (conjugated estrogens/medroxyprogesterone acetate tablets) because certain lots for this product may not meet the dissolution specification for conjugated estrogens.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Prempro (Conjugated Estrogen/Medroxyprogesterone Acetate) tablets 0.625 mg/2.5 mg, 1 blister card containing 28 tablets, Rx only, Wyeth Pharmaceuticals Inc., Philadelphia, PA, NDC 0046-0875-11
- Lots / codes
Lots: E67324 & E96152 Exp: 06/13
- Quantity
- 432,657 blister cards
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide and Puerto Rico
- Initiated
- May 31, 2013 · Voluntary: Firm initiated
- Classified
- June 28, 2013
- Reported
- July 10, 2013
- Ended
- April 6, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Medroxyprogesterone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.